Jim McIsaac/Getty Images

Zach Britton receives stem cell injection, likely done for the season

1 Comment

Orioles closer Zach Britton is likely done for the remainder of the 2017 season after receiving a stem cell injection in his left knee, Peter Schmuck and Jon Meoli of the Baltimore Sun report. Britton has been battling knee problems for most of the season.

The Orioles are still technically in the AL Wild Card race, entering play Thursday 5.5 games behind the Twins for the second Wild Card slot. With only nine games remaining, however, the 73-80 Orioles are likely being realistic about their chances and not taking any unnecessary risks with Britton.

Britton, 29, put up a 2.89 ERA with 15 saves and a 29/18 K/BB ratio in 37 1/3 innings this season. He will be eligible for arbitration for the fourth and final time this offseason.

Report: A’s trying to finish deal for Jeurys Familia

Getty Images
Leave a comment

The Athletics appear to be closing in on a deal for Mets’ right-hander Jeurys Familia, according to reports from ESPN’s Buster Olney. Nothing has been finalized just yet, however, as the Mets confirmed that they would not be announcing a trade tonight and Ken Rosenthal of The Athletic points out that other teams may still be in the mix for Familia’s services. It’s not clear what the A’s would be giving up in any potential deal for the reliever.

Familia, 28, has been pitching well this season. He currently sports a 2.88 ERA, 3.1 BB/9 and 9.5 SO/9 through 40 2/3 innings — across-the-board improvements from his last run with the Mets in 2017 — and has racked up 17 saves to boot. He’s due another $3 million for the remainder of 2018, and Rosenthal adds that the club is willing to throw some cash in the deal in order to guarantee a better return for the closer.

While the A’s have one of the better bullpens in the American League, sitting seventh-best with a 3.50 ERA and 2.8 fWAR, they still have a ways to go in order to overtake the Mariners and Astros for a postseason berth by season’s end. Familia’s contract expires at the end of the year, but he should provide enough short-term value to give the A’s the boost they need.